Title: Delvaux M, et al. The effects of lintopride, a 5HT-4 antagonist, on oesophageal motility. Aliment Pharmacol Ther. 1995 Oct;9(5):563-9.
105183-60-6 | Boc-l-homoser-obzl | AA008ZSI | MFCD01861338
1158406-56-4 | (4-(Oxazolo[4,5-b]pyridin-2-yl)morpholin-2-yl)methanamine dihydrochloride | AA0090FJ | MFCD11696374
1033693-03-6 | N-(3-Amino-1-methylpropyl)-n-ethyl-n-methylamine | AA0090R2 | MFCD10686556
1092352-76-5 | 5-Bromo-2-hydroxy-6-methyl-4-(trifluoromethyl)nicotinonitrile | AA0090WA | MFCD11501053
1207176-84-8 | 1,3,5-Triazine, 2,4-diphenyl-6-(9,9'-spirobi[9H-fluoren]-2-yl)- | AA0091G1 | MFCD30721570
1175275-00-9 | 1-Cyclohexyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrazole | AA0091ZC | MFCD16659787
1187928-89-7 | 2,3-Dihydro-1H-indole-6-carbonitrile | AA0092BV | MFCD08544327
1187932-05-3 | (R)-Benzyl 2-(chloromethyl)pyrrolidine-1-carboxylate | AA0092MU | MFCD08061231
1189106-92-0 | 7-Bromo-2,8-dimethylquinoline-3-carboxylic acid | AA0093EX | MFCD12675072
1202769-66-1 | 2-(5-Methyl-1,2-oxazol-3-yl)but-3-yn-2-ol | AA0093PC | MFCD21364447
